John T. Granton
Expertise in
8
conditions

John T. Granton

Rm 18-365, 600 University Avenue, 
Toronto, ON, CA 
Expertise in
8
conditions
Rm 18-365, 600 University Avenue, 
Toronto, ON, CA 
OverviewLocationsClinical Research

Overview

John Granton practices in Toronto, Canada. Mr. Granton is highly rated in 8 conditions, according to our data. His top areas of expertise are Pulmonary Hypertension, Hypertension, Pulmonary Embolism, Lung Transplant, and Heart Transplant.

His clinical research consists of co-authoring 174 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Rm 18-365, 600 University Avenue, Toronto, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Active_not_recruiting
Publish Date: June 24, 2025
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
Olaparib for Pulmonary Arterial Hypertension: a Multicenter Clinical Trial
Olaparib for Pulmonary Arterial Hypertension: a Multicenter Clinical Trial
Enrollment Status: Terminated
Publish Date: February 12, 2025
Intervention Type: Drug
Study Drug: Olaparib
Study Phase: Phase 1/Phase 2
Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension: Intervention With Repeat Dosing of eNOS-enhanced EPCs
Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension: Intervention With Repeat Dosing of eNOS-enhanced EPCs
Enrollment Status: Terminated
Publish Date: January 31, 2025
Intervention Type: Biological
Study Drug: Autologous EPCs transfected with human eNOS
Study Phase: Phase 2/Phase 3
DSC-COVID-19: An Open-label Study on the Safety and Efficacy of Decidual Stromal Cells in Respiratory Failure Induced by COVID-19
DSC-COVID-19: An Open-label Study on the Safety and Efficacy of Decidual Stromal Cells in Respiratory Failure Induced by COVID-19
Enrollment Status: Completed
Publish Date: February 05, 2024
Intervention Type: Biological
Study Phase: Not Applicable
Phase 3, Multicenter, Randomized, Double-blind, Placebo Controlled Withdrawal Study of Pulmonary Arterial Hypertension(PAH) Subjects With LTOT Use That Have Demonstrated Improved Exercise Tolerance With the Use of Inhaled Nitric Oxide (INO)
Phase 3, Multicenter, Randomized, Double-blind, Placebo Controlled Withdrawal Study of Pulmonary Arterial Hypertension(PAH) Subjects With LTOT Use That Have Demonstrated Improved Exercise Tolerance With the Use of Inhaled Nitric Oxide (INO)
Enrollment Status: Withdrawn
Publish Date: February 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
Feasibility and Efficacy Of Negative Pressure Ventilation in Fontan populatioN: Cardiovascular Flow Assessment by Magnetic Resonance Imaging
Feasibility and Efficacy Of Negative Pressure Ventilation in Fontan populatioN: Cardiovascular Flow Assessment by Magnetic Resonance Imaging
Enrollment Status: Completed
Publish Date: June 01, 2018
Intervention Type: Device
Study Phase: Phase 1
View 5 Less Clinical Trials

174 Total Publications

Pre- and post-capillary exercise contributions to pulmonary hypertension in adults > 45 years.
Pre- and post-capillary exercise contributions to pulmonary hypertension in adults > 45 years.
Journal: Journal of applied physiology (Bethesda, Md. : 1985)
Published: July 07, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Granton's expertise for a condition
ConditionClose
View All 24 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile